Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

Deus Thindwa; Maria Garcia Quesada; Yang Liu; Julia Bennett; Cheryl Cohen; Maria Deloria Knoll; Anne von Gottberg; Kyla Hayford; Stefan Flasche

doi:10.1016/j.vaccine.2020.06.047

Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

Deus Thindwa, Maria Garcia Quesada, Yang Liu, Julia Bennett, Cheryl Cohen, Maria Deloria Knoll, Anne von Gottberg, Kyla Hayford, Stefan Flasche

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

20 Scopus citations

Original language	English (US)
Pages (from-to)	5398-5401
Number of pages	4
Journal	Vaccine
Volume	38
Issue number	34
DOIs	https://doi.org/10.1016/j.vaccine.2020.06.047
State	Published - Jul 22 2020

Keywords

COVID-19
Influenza vaccines
PPV23 vaccine
Transmission

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2020.06.047

Cite this

@article{464e7303a9624248b925d6ddf2ac9455,

title = "Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality",

keywords = "COVID-19, Influenza vaccines, PPV23 vaccine, Transmission",

author = "Deus Thindwa and {Garcia Quesada}, Maria and Yang Liu and Julia Bennett and Cheryl Cohen and Knoll, {Maria Deloria} and {von Gottberg}, Anne and Kyla Hayford and Stefan Flasche",

note = "Funding Information: DT is funded by the National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens (MPRU) from the UK Government. MGQ, MDK, KH, and JB, were supported by the World Health Organisation (WHO), as a subaward from a Bill and Melinda Gates Foundation (BMGF) grant [OPP1189065/INV-010429]. YL is funded by the National Institute for Health Research (NIHR; 16/137/109) and the BMGF (INV-003174). CC and AvG receive grant support through their institution from Sanofi Pasteur. SF is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant number 208812/Z/17/Z). The funders had no involvement in the study design; collection, analysis and interpretation of data; writing of the report; or decision to submit the article for publication. However, Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand who are employed by WHO provided helpful comments on the design of the study, the interpretation of the data and the writing of the manuscript. Funding Information: DT is funded by the National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens (MPRU) from the UK Government. MGQ, MDK, KH, and JB, were supported by the World Health Organisation (WHO), as a subaward from a Bill and Melinda Gates Foundation (BMGF) grant [ OPP1189065/INV-010429 ]. YL is funded by the National Institute for Health Research (NIHR; 16/137/109 ) and the BMGF ( INV-003174 ). CC and AvG receive grant support through their institution from Sanofi Pasteur. SF is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant number 208812/Z/17/Z ). The funders had no involvement in the study design; collection, analysis and interpretation of data; writing of the report; or decision to submit the article for publication. However, Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand who are employed by WHO provided helpful comments on the design of the study, the interpretation of the data and the writing of the manuscript. Funding Information: We would like to thank Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand of the World Health Organization, Geneva, Switzerland, for insightful discussions at all stages of this work. We would like to thank all of the PSERENADE Team site investigators who contributed IPD surveillance data to the global serotype distribution analysis. The PSERENADE project is funded by the Bill & Melinda Gates Foundation and the World Health Organization. ",

year = "2020",

month = jul,

day = "22",

doi = "10.1016/j.vaccine.2020.06.047",

language = "English (US)",

volume = "38",

pages = "5398--5401",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "34",

}

TY - JOUR

T1 - Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

AU - Thindwa, Deus

AU - Garcia Quesada, Maria

AU - Liu, Yang

AU - Bennett, Julia

AU - Cohen, Cheryl

AU - Knoll, Maria Deloria

AU - von Gottberg, Anne

AU - Hayford, Kyla

AU - Flasche, Stefan

N1 - Funding Information: DT is funded by the National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens (MPRU) from the UK Government. MGQ, MDK, KH, and JB, were supported by the World Health Organisation (WHO), as a subaward from a Bill and Melinda Gates Foundation (BMGF) grant [OPP1189065/INV-010429]. YL is funded by the National Institute for Health Research (NIHR; 16/137/109) and the BMGF (INV-003174). CC and AvG receive grant support through their institution from Sanofi Pasteur. SF is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant number 208812/Z/17/Z). The funders had no involvement in the study design; collection, analysis and interpretation of data; writing of the report; or decision to submit the article for publication. However, Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand who are employed by WHO provided helpful comments on the design of the study, the interpretation of the data and the writing of the manuscript. Funding Information: DT is funded by the National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens (MPRU) from the UK Government. MGQ, MDK, KH, and JB, were supported by the World Health Organisation (WHO), as a subaward from a Bill and Melinda Gates Foundation (BMGF) grant [ OPP1189065/INV-010429 ]. YL is funded by the National Institute for Health Research (NIHR; 16/137/109 ) and the BMGF ( INV-003174 ). CC and AvG receive grant support through their institution from Sanofi Pasteur. SF is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant number 208812/Z/17/Z ). The funders had no involvement in the study design; collection, analysis and interpretation of data; writing of the report; or decision to submit the article for publication. However, Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand who are employed by WHO provided helpful comments on the design of the study, the interpretation of the data and the writing of the manuscript. Funding Information: We would like to thank Adam L. Cohen, Shalini Desai, Raymond Hutubessy and Ann Lindstrand of the World Health Organization, Geneva, Switzerland, for insightful discussions at all stages of this work. We would like to thank all of the PSERENADE Team site investigators who contributed IPD surveillance data to the global serotype distribution analysis. The PSERENADE project is funded by the Bill & Melinda Gates Foundation and the World Health Organization.

PY - 2020/7/22

Y1 - 2020/7/22

KW - COVID-19

KW - Influenza vaccines

KW - PPV23 vaccine

KW - Transmission

UR - http://www.scopus.com/inward/record.url?scp=85087021304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087021304&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2020.06.047

DO - 10.1016/j.vaccine.2020.06.047

M3 - Comment/debate

C2 - 32600911

AN - SCOPUS:85087021304

SN - 0264-410X

VL - 38

SP - 5398

EP - 5401

JO - Vaccine

JF - Vaccine

IS - 34

ER -

Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this